journal
MENU ▼
Read by QxMD icon Read
search

Lancet Respiratory Medicine

journal
https://www.readbyqxmd.com/read/30413397/corrections
#1
(no author information available yet)
No abstract text is available yet for this article.
November 6, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30391258/round-up-of-the-european-society-of-intensive-care-medicine-congress-2018
#2
Márcia Costa
No abstract text is available yet for this article.
October 31, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30366663/the-tragic-legacy-of-the-sennan-asbestos-disaster
#3
Talha Khan Burki
No abstract text is available yet for this article.
October 23, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30361119/paediatric-acute-respiratory-distress-syndrome-incidence-and-epidemiology-pardie-an-international-observational-study
#4
Robinder G Khemani, Lincoln Smith, Yolanda M Lopez-Fernandez, Jeni Kwok, Rica Morzov, Margaret J Klein, Nadir Yehya, Douglas Willson, Martin C J Kneyber, Jon Lillie, Analia Fernandez, Christopher J L Newth, Philippe Jouvet, Neal J Thomas
BACKGROUND: Paediatric acute respiratory distress syndrome (PARDS) is associated with high mortality in children, but until recently no paediatric-specific diagnostic criteria existed. The Pediatric Acute Lung Injury Consensus Conference (PALICC) definition was developed to overcome limitations of the Berlin definition, which was designed and validated for adults. We aimed to determine the incidence and outcomes of children who meet the PALICC definition of PARDS. METHODS: In this international, prospective, cross-sectional, observational study, 145 paediatric intensive care units (PICUs) from 27 countries were recruited, and over a continuous 5 day period across 10 weeks all patients were screened for enrolment...
October 22, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30361118/personalising-care-of-acute-respiratory-distress-syndrome-according-to-patients-age
#5
Daniele De Luca
No abstract text is available yet for this article.
October 22, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30343031/long-term-opioid-use-among-respiratory-patients
#6
Talha Khan Burki
No abstract text is available yet for this article.
October 17, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30343030/blood-eosinophils-for-the-management-of-copd-patients
#7
Leonardo M Fabbri, Bianca Beghé, Alberto Papi
No abstract text is available yet for this article.
October 17, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30343029/opening-the-black-box-of-machine-learning
#8
EDITORIAL
The Lancet Respiratory Medicine
No abstract text is available yet for this article.
October 17, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30343028/comparative-effectiveness-of-laba-ics-versus-lama-as-initial-treatment-in-copd-targeted-by-blood-eosinophils-a-population-based-cohort-study
#9
Samy Suissa, Sophie Dell'Aniello, Pierre Ernst
BACKGROUND: Long-acting β2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are the recommended initial maintenance treatment for chronic obstructive pulmonary disease (COPD), with almost all LABAs dispensed in fixed combination with inhaled corticosteroids (LABA-ICS). We compared the effectiveness and safety of LABA-ICS versus LAMA treatment initiation as a function of blood eosinophilia, a potential biomarker of ICS effectiveness, in a real-world setting. METHODS: In this population-based cohort study, we identified a cohort of patients with COPD initiating treatment with a LAMA or LABA-ICS during 2002-15, age 55 years or older, from the UK's Clinical Practice Research Datalink...
October 17, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30322829/corrections
#10
(no author information available yet)
No abstract text is available yet for this article.
October 12, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30309788/airway-reflux-an-emerging-topic-in-respiratory-medicine
#11
Adalberto Pacheco, Christian Domingo
No abstract text is available yet for this article.
October 8, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30297271/united-to-end-tuberculosis
#12
Ammara Mushtaq
No abstract text is available yet for this article.
October 5, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30297270/investigating-blood-eosinophil-count-thresholds-in-patients-with-copd
#13
Richard E K Russell, Mona Bafadhel
No abstract text is available yet for this article.
October 5, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30293856/corrections
#14
(no author information available yet)
No abstract text is available yet for this article.
October 4, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30293855/hygge-but-harmful-wood-burning-stoves-under-scrutiny
#15
Talha Khan Burki
No abstract text is available yet for this article.
October 4, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30292762/asthma-and-immunology-a-call-for-papers-for-aaaai
#16
Rachel Marshall
No abstract text is available yet for this article.
October 3, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30274956/machine-learning-for-real-time-prediction-of-complications-in-critical-care-a-retrospective-study
#17
Alexander Meyer, Dina Zverinski, Boris Pfahringer, Jörg Kempfert, Titus Kuehne, Simon H Sündermann, Christof Stamm, Thomas Hofmann, Volkmar Falk, Carsten Eickhoff
BACKGROUND: The large amount of clinical signals in intensive care units can easily overwhelm health-care personnel and can lead to treatment delays, suboptimal care, or clinical errors. The aim of this study was to apply deep machine learning methods to predict severe complications during critical care in real time after cardiothoracic surgery. METHODS: We used deep learning methods (recurrent neural networks) to predict several severe complications (mortality, renal failure with a need for renal replacement therapy, and postoperative bleeding leading to operative revision) in post cardiosurgical care in real time...
September 28, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30270136/2018-annual-congress-of-the-european-respiratory-society
#18
Priya Venkatesan
No abstract text is available yet for this article.
September 27, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30232049/deep-learning-for-classifying-fibrotic-lung-disease-on-high-resolution-computed-tomography-a-case-cohort-study
#19
Simon L F Walsh, Lucio Calandriello, Mario Silva, Nicola Sverzellati
BACKGROUND: Based on international diagnostic guidelines, high-resolution CT plays a central part in the diagnosis of fibrotic lung disease. In the correct clinical context, when high-resolution CT appearances are those of usual interstitial pneumonia, a diagnosis of idiopathic pulmonary fibrosis can be made without surgical lung biopsy. We investigated the use of a deep learning algorithm for provision of automated classification of fibrotic lung disease on high-resolution CT according to criteria specified in two international diagnostic guideline statements: the 2011 American Thoracic Society (ATS)/European Respiratory Society (ERS)/Japanese Respiratory Society (JRS)/Latin American Thoracic Association (ALAT) guidelines for diagnosis and management of idiopathic pulmonary fibrosis and the Fleischner Society diagnostic criteria for idiopathic pulmonary fibrosis...
September 14, 2018: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/30232048/triple-therapy-with-budesonide-glycopyrrolate-formoterol-fumarate-with-co-suspension-delivery-technology-versus-dual-therapies-in-chronic-obstructive-pulmonary-disease-kronos-a-double-blind-parallel-group-multicentre-phase-3-randomised-controlled-trial
#20
Gary T Ferguson, Klaus F Rabe, Fernando J Martinez, Leonardo M Fabbri, Chen Wang, Masakazu Ichinose, Eric Bourne, Shaila Ballal, Patrick Darken, Kiernan DeAngelis, Magnus Aurivillius, Paul Dorinsky, Colin Reisner
BACKGROUND: Inhaled corticosteroids have been used in patients with chronic obstructive pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not well known. We aimed to compare the efficacy of a triple therapy with corresponding dual therapies in symptomatic patients with moderate to very severe COPD, without a requirement for a history of exacerbations. METHODS: In this double-blind, parallel-group, multicentre phase 3 randomised controlled trial, we recruited patients from hospitals and care centres in Canada, China, Japan, and the USA...
September 14, 2018: Lancet Respiratory Medicine
journal
journal
47869
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"